Home › Ulcerative Colitis › Texas › San Antonio
Pag-aaral pangklinika para sa Ulcerative Colitis sa San Antonio, TX
16 pag-aaral para sa Ulcerative Colitis ang naghahanap ng mga kalahok sa mga site sa loob at paligid ng San Antonio (sa loob ng humigit-kumulang 30 milya). Buksan ang pag-aaral upang makita kung sino ang makakasali at kung paano makipag-ugnayan sa koponan ng pag-aaral.
Opisyal na teksto ng pag-aaral (English)
A Study of Eltrekibart and Mirikizumab in Adult Patients With Moderately to Severely Active Ulcerative Colitis
Nagre-recruitPhase 2
- Gastroenterology Research of San Antonio, San Antonio
Confirmatory Clinical Study in Active Ulcerative Colitis
Nagre-recruitPhase 2
- Southern Star Research Institute, San Antonio
A Study of Long-acting Antibodies Alone and in Combinations for Moderate to Severe Ulcerative Colitis
Nagre-recruitPhase 2
- Site 002, San Antonio
Study of XmAb942 in Healthy Participants and Participants With Ulcerative Colitis
Nagre-recruitPhase 1/2Malugod na tinatanggap ang malusog na boluntaryo
- Xencor Investigative Site, San Antonio
Study of Advanced Therapies for the Treatment of Adult Participants With Moderately to Severely Active Crohn's Disease or Ulcerative Colitis
Nagre-recruitPhase 2
- Southern Star Research Institute /ID# 280822, San Antonio
A Protocol of Icotrokinra Therapy in Adult and Adolescent Participants With Moderately to Severely Active Ulcerative Colitis
Nagre-recruitPhase 3
- Southern Star Research Institute, LLC, San Antonio
Mirikizumab Administered at the Same Time as Tirzepatide in Adult Participants With Moderately to Severely Active Ulcerative Colitis and Obesity or Overweight: Phase 3b Study
Nagre-recruitPhase 3
- Gastroenterology Research of San Antonio, San Antonio
- Southern Star Research Institute, San Antonio
A Master Protocol (IIBD): A Study of Multiple Drugs in Adults With Ulcerative Colitis or Crohn's Disease
Nagre-recruitPhase 2
- Southern Star Research Institute, San Antonio
LY4268989 (MORF-057) Co-Administered With Mirikizumab in Adults With Moderately to Severely Active Ulcerative Colitis:
Nagre-recruitPhase 2
- Southern Star Research Institute, San Antonio
LY4268989 in Adults With Moderately to Severely Active Ulcerative Colitis
Nagre-recruitPhase 2
- Southern Star Research Institute, San Antonio
A Study of Vedolizumab With Tofacitinib in Adults With Ulcerative Colitis (UC)
Nagre-recruitPhase 4
- Gastroenterology Research of San Antonio, LLC, San Antonio
A Maintenance Study to Investigate the Efficacy and Safety of Duvakitug in Participants With Moderately to Severely Active Ulcerative Colitis
Nagre-recruitPhase 3
- Gastroenterology Research of San Antonio LLC - Site Number: 8400054, San Antonio
Extension Study of Long-term Safety and Efficacy of Tulisokibart in Participants With Crohn's Disease or Ulcerative Colitis (MK-7240-011)
Nagre-recruitPhase 3
- Southern Star Research Institute ( Site 0299), San Antonio
A Study of JNJ-78934804 in Participants With Moderately to Severely Active Ulcerative Colitis
Nagre-recruitPhase 3
- Southern Star Research Institute, LLC, San Antonio
An Induction Study to Investigate the Efficacy and Safety of Duvakitug in Participants With Moderately to Severely Active Ulcerative Colitis
Nagre-recruitPhase 3
- Gastroenterology Research of San Antonio LLC - Site Number: 8400054, San Antonio
An Observational Study of Etrasimod in Adult Patients With Moderate to Severe Ulcerative Colitis
Nagre-recruitObservasyonal na pag-aaral
- Brooke Army Medical center, San Antonio
- Brooke Army Medical center, San Antonio
Pag-aaral para sa Ulcerative Colitis sa ibang lungsod
- New York City, NY24 pag-aaral
- Orlando, FL23 pag-aaral
- Miami, FL22 pag-aaral
- Houston, TX18 pag-aaral
- San Diego, CA16 pag-aaral
- Tacoma, WA15 pag-aaral
- Chicago, IL15 pag-aaral
- Colorado Springs, CO14 pag-aaral
- St. Louis, MO14 pag-aaral
- Tyler, TX14 pag-aaral
- Los Angeles, CA13 pag-aaral
- Washington, DC12 pag-aaral
Iba pang pag-aaral sa San Antonio
- Non-Small Cell Lung Cancer59 pag-aaral
- Colorectal Cancer46 pag-aaral
- Kanser sa Suso46 pag-aaral
- Metastatic Cancer44 pag-aaral
- Kanser (lahat ng uri)41 pag-aaral
- Obesity39 pag-aaral
- Type 2 Diabetes37 pag-aaral
- Overweight33 pag-aaral
- Kanser sa Pancreas31 pag-aaral
- Kanser sa Ovary31 pag-aaral
- Kanser sa Prostate28 pag-aaral
- Kanser ng Endometrium27 pag-aaral
Mula sa ClinicalTrials.gov, na-kuha noong Okt 1, 2026. Ang bawat pag-aaral ay may sariling pamantayan sa eligibility; ang koponan ng pag-aaral ang magdedesisyon kung sino ang makakasali.